Anastasia Shneyderman
Insilicos (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Estrogen and related hormone effects, Glioma Diagnosis and Treatment, Breast Cancer Treatment Studies, Genetic Neurodegenerative Diseases
Most-Cited Works
- → AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor(2023)301 cited
- → Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform(2022)92 cited
- → HDinHD: A Rich Data Portal for Huntington’s Disease Research(2021)25 cited
- → Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform(2023)18 cited
- → High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders(2022)17 cited
- → Precious3GPT: Multimodal Multi-Species Multi-Omics Multi-Tissue Transformer for Aging Research and Drug Discovery(2024)14 cited
- → COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity(2021)12 cited
- → AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor(2022)9 cited
- → Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy(2023)9 cited
- → Comparative analysis of Endoxifen, Tamoxifen and Fulvestrant: A Bioinformatics Approach to Uncover Mechanisms of Action in Breast Cancer(2024)6 cited